Acute and fulminant forms of autoimmune hepatitis were recognized by the International
Autoimmune Hepatitis Group in 1992 when it codified diagnostic criteria and waived the …

We read with great interest the manuscript by de Martin et al., 1 reporting early predictive
factors for a non-response to corticosteroid therapy in acute severe autoimmune hepatitis …

Background and aim Acute severe autoimmune hepatitis (AS-AIH) is a rare cause of acute
liver failure (ALF), which is often neglected and delayed in treatment. The purpose of this …

Autoimmune hepatitis (AIH) is a disease of unknown etiology, its hallmark being ongoing
hepatic inflammation. By its very nature, it is a chronic condition, although increasingly, we …

Background With few data regarding treatment and outcome of patients with AIH outside of
large centres we present such a study of patients with AIH in 28 UK hospitals of varying size …

Patients transplanted for autoimmune hepatitis (AIH) are at risk of recurrent disease. Our
current practice is to maintain long‐term low‐dose corticosteroids with additional …

AIM: To investigate the clinical features, response to corticosteroids, and prognosis of
autoimmune hepatitis (AIH)-induced liver failure in China. METHODS: A total of 22 patients …

Presentation of autoimmune hepatitis (AIH) can differ from nonacute to acute autoimmune
hepatitis (A‐AIH) with jaundice and acute severe autoimmune hepatitis (AS‐AIH) with …

Background and aims Diagnosis of the acute presentation of autoimmune hepatitis (AIH) is
difficult because patients do not always show typical clinicopathological features of AIH …

Background and aims Autoimmune hepatitis presenting as acute on chronic liver failure (AIH-
ACLF) is a novel entity with limited data on clinical course and management. We assessed …